A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

Decio Eizirik (Uitvinder), Alexander Balhuizen (Uitvinder), Nick Devoogdt (Uitvinder), Sam Massa (Uitvinder), Luc Bouwens (Uitvinder), Iris Mathijs (Uitvinder)

Onderzoeksoutput: Patent

Samenvatting

The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).
Originele taal-2English
OctrooinummerWO2017182603
StatusPublished - 2017

Vingerafdruk

Duik in de onderzoeksthema's van 'A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells'. Samen vormen ze een unieke vingerafdruk.

Citeer dit